Biology & drug discovery · South San Francisco, US · founded 2024
Xaira Therapeutics: who founded it, who funds it
Xaira Therapeutics is a South San Francisco AI drug discovery lab founded in 2024 by Marc Tessier-Lavigne, David Baker, Vik Bajaj and Hetu Kamisetty, who came from Stanford, UW, DeepMind and Meta. What it is building: aI-first drug discovery launched with $1B. It has raised $1B in disclosed rounds, most recently a Series A of $1B in April 2024, led by ARCH Venture Partners and Foresite Capital. It has not released anything outsiders can use yet.
- Founders
- Marc Tessier-Lavigne (ex-Stanford), David Baker (ex-UW), Vik Bajaj (ex-Google DeepMind), Hetu Kamisetty (ex-Meta)
- Founders from
- ex-Stanford, ex-UW, ex-Google DeepMind, ex-Meta
- Location
- South San Francisco, US (North America)
- Valuation
- ·
- Raised
- $1B disclosed
- Investors
- ARCH Venture Partners lead, Foresite Capital lead
- What ships
- Research only
Rounds
| Date | Round | Amount | Valuation | Lead | Source |
|---|---|---|---|---|---|
| Apr 23, 2024 | Series A | $1B | · | ARCH Venture Partners, Foresite Capital | neolabs.fyi |
Sources
- neolabs.fyi neolabs.fyi
News
- Oct 2, 2026
-
Sep 9, 2026
+1 more coverage
- Revelio Labs Xaira Therapeutics Number of Employees 2026 | Employee Count & Headcount Data
-
Jul 6, 2026
- Mar 26, 2026
-
Mar 17, 2026
+1 more coverage
- Fierce Biotech Behind the curtain: What Xaira is building after its $1B fundraise
- Mar 17, 2026
Same research area
- Chai Discovery $3.8B · San Francisco, US
- Merge Labs $850M · San Francisco, US
- EvolutionaryScale · · New York, US
- Isomorphic Labs · · London, UK
- Latent Labs · · London, UK